CRISPR gene drives bias inheritance in pests, advancing population-level control while raising questions about resistance and ...
Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, ...